Efg Capital International Corp. »

Sarepta Therapeutics shares owned by Efg Capital International Corp.

Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by Efg Capital International Corp. from 13F filings

Historical chart of Efg Capital International Corp. investment in Sarepta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics held by Efg Capital International Corp. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics by Efg Capital International Corp.

Quarter filed Position value Share count Share price at filing
2023-06-30 $231k 2.0k 114.52

More positions owned by Efg Capital International Corp.

Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Apple (AAPL)
Amazon (AMZN)
Mastercard Incorporated Cl A (MA)
UnitedHealth (UNH)
Verisk Analytics (VRSK)
Alphabet Cap Stk Cl C (GOOG)
Johnson & Johnson (JNJ)
Pepsi (PEP)
Cme (CME)
Adobe Systems Incorporated (ADBE)
Tesla Motors (TSLA)
Netflix (NFLX)
JPMorgan Chase & Co. (JPM)

View all positions for Efg Capital International Corp.

Top funds holding Sarepta Therapeutics

Vanguard Group
BlackRock
Henderson Group
venBio Select Advisor
Wellington Management Company
Farallon Capital Management
Citadel Advisors
Bank of New York Mellon
T. Rowe Price Investment Management
EcoR1 Capital
Jpmorgan Chase & Co
Logos Global Management
Geode Capital Management
Deutsche Bank Aktiengesellschaft
FMR

View all funds holding Sarepta Therapeutics